Search

Background: Hydrated electrons, which are short‐lived products of radiolysis in water, increase the optical absorption of water, providing a pathway toward near‐tissue‐equivalent clinical radiation dosimeters. This has been demonstrated in high‐dose‐per‐pulse radiochemistry research, but, owing to the weak absorption signal, its application in existing low‐dose‐per‐pulse radiotherapy provided by clinical linear accelerators (linacs) has yet to be investigated. Purpose: The aims of this study were to measure the optical absorption associated with hydrated electrons produced by clinical linacs and to assess the suitability of the technique for radiotherapy (⩽ 1 cGy per pulse) applications. Methods: 40 mW of 660‐nm laser light was sent five passes through deionized water contained in a 10×4×$\times 4\times$2 cm3 glass‐walled cavity by using four broadband dielectric mirrors, two on each side of the cavity. The light was collected with a biased silicon photodetector. The water cavity was then irradiated by a Varian TrueBeam linac with both photon (10 MV FFF, 6 MV FFF, 6 MV) and electron beams (6 MeV) while monitoring the transmitted laser power for absorption transients. Radiochromic EBT3 film measurements were also performed for comparison. Results: Examination of the absorbance profiles showed clear absorption changes in the water when radiation pulses were delivered. Both the amplitude and the decay time of the signal appeared consistent with the absorbed dose and the characteristics of the hydrated electrons. By using literature value for the hydrated electron radiation chemical yield (3.0±0.3), we inferred doses of 2.1±0.2 mGy (10 MV FFF), 1.3±0.1 mGy (6 MV FFF), 0.45±0.06 mGy (6 MV) for photons, and 0.47±0.05 mGy (6 MeV) for electrons, which differed from EBT3 film measurements by 0.6%, 0.8%, 10%, and 15.7%, respectively. The half‐life of the hydrated electrons in the solution was ∼ 24 μ$\umu$s. Conclusions: By measuring 660‐nm laser light transmitted through a cm‐scale, multi‐pass water cavity, we observed absorption transients consistent with hydrated electrons generated by clinical linac radiation. The agreement between our inferred dose and EBT3 film measurements suggests this proof‐of‐concept system represents a viable pathway toward tissue‐equivalent dosimeters for clinical radiotherapy applications. [ABSTRACT FROM AUTHOR]

Purpose: To quantify and verify the dosimetric impact of high‐dose rate (HDR) source positional uncertainty in brachytherapy, and to introduce a model for three‐dimensional (3D) position tracking of the HDR source based on a two‐dimensional (2D) measurement. This model has been utilized for the development of a comprehensive source quality assurance (QA) method using radiochromic film (RCF) dosimetry including assessment of different digitization uncertainties. Methods: An algorithm was developed and verified to generate 2D dose maps of the mHDR‐V2 192Ir source (Elekta, Veenendaal, Netherlands) based on the AAPM TG‐43 formalism. The limits of the dosimetric error associated with source (0.9 mm diameter) positional uncertainty were evaluated and experimentally verified with EBT3 film measurements for 6F (2.0 mm diameter) and 4F (1.3 mm diameter) size catheters at the surface (4F, 6F) and 10 mm further (4F only). To quantify this uncertainty, a source tracking model was developed to incorporate the unique geometric features of all isodose lines (IDLs) within any given 2D dose map away from the source. The tracking model normalized the dose map to its maximum, then quantified the IDLs using blob analysis based on features such as area, perimeter, weighted centroid, elliptic orientation, and circularity. The Pearson correlation coefficients (PCCs) between these features and source coordinates (x, y, z, θy, θz) were calculated. To experimentally verify the accuracy of the tracking model, EBT3 film pieces were positioned within a Solid Water® (SW) phantom above and below the source and they were exposed simultaneously. Results: The maximum measured dosimetric variations on the 6F and 4F catheter surfaces were 39.8% and 36.1%, respectively. At 10 mm further, the variation reduced to 2.6% for the 4F catheter which is in agreement with the calculations. The source center (x, y) was strongly correlated with the low IDL‐weighted centroid (PCC = 0.99), while the distance to source (z) was correlated with the IDL areas (PCC = 0.96) and perimeters (PCC = 0.99). The source orientation θy was correlated with the difference between high and low IDL‐weighted centroids (PCC = 0.98), while θz was correlated with the elliptic orientation of the 60–90% IDLs (PCC = 0.97) for a maximum distance of z = 5 mm. Beyond 5 mm, IDL circularity was significant, therefore limiting the determination of θz (PCC ≤ 0.48). The measured positional errors from the film sets above and below the source indicated a source position at the bottom of the catheter (−0.24 ± 0.07 mm). Conclusions: Isodose line features of a 2D dose map away from the HDR source can reveal its spatial coordinates. RCF was shown to be a suitable dosimeter for source tracking and dosimetry. This technique offers a novel source QA method and has the potential to be used for QA of commercial and customized applicators. [ABSTRACT FROM AUTHOR]